Anne-Laure joined Apposite in 2015, where she is involved in originating, executing and managing investments. She currently serves on the Board of NIM Genetics. She has over 6 years of experience in private equity and M&A and was most recently CFO of Nuage Labs, a Paris based technology start-up . She was previously an Executive in the investment team at Bridgepoint where she focused on investment execution and due diligence. She started her career in 2009 within the healthcare M&A team at Rothschild Global Financial Advisory group where she worked on a number of high profile deals in the European healthcare sector. Anne-Laure is a graduate of ESCP Europe and a CFA charterholder.